Market Cap ₹147 Cr.
Stock P/E -30.7
P/B 0.9
Current Price ₹18.7
Book Value ₹ 21.7
Face Value 10
52W High ₹39.5
Dividend Yield 0%
52W Low ₹ 15.5
JHS Svendgaard Laboratories Ltd is a prominent Indian company specializing in oral care and personal hygiene products. Founded in 1995, the company has established itself as a leading manufacturer and exporter of dental care products, including toothbrushes, toothpaste, and mouthwash. With a strong commitment to quality, innovation, and sustainability, JHS Svendgaard has earned a stellar reputation in the oral care industry. The company's state-of-the-art manufacturing facilities adhere to global quality standards, ensuring the production of safe and effective oral hygiene solutions. JHS Svendgaard's extensive product range caters to both domestic and international markets, serving consumers, retailers, and healthcare professionals. Their dedication to research and development has led to the creation of innovative dental care products, making them a trusted name in the industry. Overall, JHS Svendgaard Laboratories Ltd is dedicated to promoting oral health and well-being through its high-quality oral care solutions.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 21 | 19 | 21 | 21 | 22 | 22 | 19 | 19 | 14 | 22 |
Other Income | 3 | 2 | 1 | 3 | 1 | 7 | 1 | 0 | 2 | 1 |
Total Income | 24 | 21 | 23 | 24 | 23 | 29 | 20 | 19 | 17 | 23 |
Total Expenditure | 22 | 19 | 23 | 23 | 24 | 25 | 22 | 19 | 14 | 21 |
Operating Profit | 2 | 2 | 0 | 1 | -1 | 4 | -2 | 1 | 2 | 2 |
Interest | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 2 | 2 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -19 | 0 | 0 | 0 | 0 |
Profit Before Tax | -0 | -0 | -2 | -1 | -3 | -17 | -4 | -1 | 1 | 0 |
Provision for Tax | -0 | 4 | 2 | -0 | -0 | -6 | -1 | -0 | 1 | 1 |
Profit After Tax | -0 | -4 | -4 | -1 | -3 | -11 | -3 | -1 | 0 | -1 |
Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | -0 |
Profit After Adjustments | 0 | -4 | -4 | -1 | -3 | -11 | -3 | -1 | 0 | -1 |
Adjusted Earnings Per Share | 0 | -0.7 | -0.6 | -0.1 | -0.4 | -1.4 | -0.4 | -0.1 | 0 | -0.1 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 60 | 35 | 55 | 100 | 105 | 140 | 124 | 139 | 101 | 86 | 96 | 74 |
Other Income | 4 | 4 | 1 | 1 | 0 | 5 | 7 | 14 | 8 | 9 | 16 | 4 |
Total Income | 64 | 39 | 56 | 101 | 105 | 145 | 131 | 153 | 108 | 96 | 113 | 79 |
Total Expenditure | 48 | 39 | 59 | 94 | 93 | 127 | 125 | 137 | 99 | 87 | 107 | 76 |
Operating Profit | 16 | 0 | -3 | 7 | 12 | 19 | 6 | 16 | 9 | 9 | 5 | 3 |
Interest | 10 | 14 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 |
Depreciation | 14 | 15 | 12 | 10 | 6 | 7 | 7 | 9 | 7 | 7 | 7 | 7 |
Exceptional Income / Expenses | 8 | -6 | -7 | -18 | -0 | 27 | 0 | -11 | 0 | 0 | -19 | 0 |
Profit Before Tax | 0 | -35 | -22 | -22 | 5 | 38 | -2 | -6 | 1 | 0 | -22 | -4 |
Provision for Tax | 4 | -6 | 0 | 0 | -17 | 12 | -0 | -1 | -0 | 4 | -5 | 1 |
Profit After Tax | -4 | -29 | -22 | -22 | 22 | 26 | -2 | -5 | 1 | -4 | -17 | -5 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | -0 | 0 | 1 | 0 |
Profit After Adjustments | -4 | -29 | -22 | -22 | 22 | 26 | -1 | -2 | 1 | -4 | -15 | -5 |
Adjusted Earnings Per Share | -1.6 | -12 | -9.2 | -5.7 | 5 | 4.3 | -0.1 | -0.3 | 0.2 | -0.6 | -2.4 | -0.6 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 12% | -12% | -7% | 5% |
Operating Profit CAGR | -44% | -32% | -23% | -11% |
PAT CAGR | 0% | 0% | NAN% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 4% | -4% | -5% | 10% |
ROE Average | -9% | -4% | -3% | -6% |
ROCE Average | -12% | -3% | -2% | -2% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 89 | 62 | 120 | 101 | 134 | 174 | 177 | 178 | 189 | 186 | 172 |
Minority's Interest | 0 | 0 | 0 | 0 | -0 | -0 | 4 | 7 | 9 | 9 | 8 |
Borrowings | 19 | 13 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Other Non-Current Liabilities | 7 | 1 | 1 | 1 | -16 | -4 | -4 | -3 | -4 | 1 | 6 |
Total Current Liabilities | 115 | 114 | 49 | 18 | 20 | 32 | 39 | 48 | 23 | 19 | 38 |
Total Liabilities | 231 | 190 | 170 | 121 | 138 | 203 | 216 | 230 | 218 | 215 | 225 |
Fixed Assets | 135 | 121 | 108 | 65 | 65 | 71 | 71 | 66 | 63 | 59 | 66 |
Other Non-Current Assets | 33 | 22 | 19 | 20 | 31 | 29 | 44 | 34 | 23 | 77 | 68 |
Total Current Assets | 63 | 47 | 43 | 36 | 43 | 103 | 102 | 130 | 121 | 79 | 90 |
Total Assets | 231 | 190 | 170 | 121 | 138 | 203 | 216 | 230 | 218 | 215 | 225 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 3 | 0 | 2 | 1 | 3 | 6 | 6 | 1 | 1 | 21 | 6 |
Cash Flow from Operating Activities | 60 | 28 | 7 | -4 | -4 | 14 | -11 | 10 | 12 | -9 | 19 |
Cash Flow from Investing Activities | -23 | 3 | 1 | 1 | -3 | -27 | -7 | -11 | -2 | -5 | 6 |
Cash Flow from Financing Activities | -39 | -29 | -10 | 4 | 10 | 14 | 13 | 0 | 10 | -2 | 8 |
Net Cash Inflow / Outflow | -2 | 2 | -1 | 2 | 3 | 0 | -5 | -0 | 20 | -16 | 33 |
Closing Cash & Cash Equivalent | 0 | 2 | 1 | 3 | 6 | 6 | 1 | 1 | 21 | 5 | 40 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -1.56 | -11.96 | -9.2 | -5.75 | 4.97 | 4.29 | -0.11 | -0.33 | 0.19 | -0.62 | -2.38 |
CEPS(Rs) | 4.09 | -5.85 | -4.08 | -2.96 | 6.41 | 5.4 | 0.89 | 0.64 | 1.33 | 0.43 | -1.43 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 37.13 | 25.77 | 49.71 | 25.2 | 29.41 | 28.58 | 28.97 | 29.16 | 27.56 | 28.6 | 26.55 |
Core EBITDA Margin(%) | 19.84 | -10.75 | -7.19 | 6.42 | 11.13 | 9.64 | -0.47 | 1.19 | 1.9 | -0.98 | -11.54 |
EBIT Margin(%) | 18.04 | -59.97 | -39.75 | -21.26 | 5.48 | 27.46 | -0.81 | -2.78 | 2.19 | 1.74 | -21.62 |
Pre Tax Margin(%) | 0.52 | -100.05 | -40.01 | -21.62 | 4.89 | 26.94 | -1.65 | -4.17 | 0.96 | 0.12 | -22.7 |
PAT Margin (%) | -6.31 | -81.66 | -40.09 | -21.62 | 20.88 | 18.27 | -1.34 | -3.47 | 1.33 | -4.97 | -17.44 |
Cash Profit Margin (%) | 16.55 | -39.98 | -17.75 | -11.14 | 26.93 | 23.04 | 4.36 | 2.79 | 8.52 | 3.2 | -9.68 |
ROA(%) | -1.61 | -13.68 | -12.32 | -14.88 | 16.91 | 15.25 | -0.79 | -2.17 | 0.6 | -1.98 | -7.63 |
ROE(%) | -3.68 | -38.02 | -24.39 | -20.17 | 19.53 | 17.15 | -0.95 | -2.74 | 0.76 | -2.36 | -9.37 |
ROCE(%) | 5.78 | -13.78 | -17.26 | -17.59 | 4.8 | 25.01 | -0.56 | -2.15 | 1.24 | 0.82 | -11.59 |
Receivable days | 423.93 | 280.22 | 143.38 | 58.65 | 35.73 | 72.14 | 141.83 | 195.53 | 280.04 | 162.56 | 73.58 |
Inventory Days | 59.07 | 61.5 | 48.93 | 33.41 | 34.81 | 25.93 | 27.26 | 19.07 | 31.19 | 50.23 | 48.82 |
Payable days | 634.69 | 301.86 | 117.79 | 105.68 | 122.24 | 120.92 | 134.03 | 145.67 | 208.84 | 139.67 | 150.93 |
PER(x) | 0 | 0 | 0 | 0 | 7.87 | 12.49 | 0 | 0 | 107.2 | 0 | 0 |
Price/Book(x) | 0.4 | 0.24 | 0.15 | 0.89 | 1.33 | 1.88 | 0.95 | 0.26 | 0.72 | 0.72 | 0.59 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 2.29 | 1.89 | 0.65 | 0.84 | 1.61 | 2.3 | 1.4 | 0.33 | 1.07 | 1.48 | 0.65 |
EV/Core EBITDA(x) | 8.55 | 4012.12 | -11.63 | 11.78 | 13.96 | 17.24 | 28.67 | 2.93 | 11.43 | 14.93 | 11.83 |
Net Sales Growth(%) | -52.93 | -40.8 | 56.82 | 80.91 | 4.97 | 33.54 | -11.53 | 12.09 | -27.57 | -14.4 | 11.54 |
EBIT Growth(%) | 12.96 | -296.87 | -3.94 | 3.26 | 127.05 | 580.55 | -102.58 | -284.7 | 156.75 | -32.21 | -1489.72 |
PAT Growth(%) | -439.35 | -665.94 | 23.02 | 2.42 | 201.36 | 18.78 | -106.4 | -191.19 | 127.65 | -419.53 | -291.09 |
EPS Growth(%) | -347.17 | -665.96 | 23.09 | 37.52 | 186.54 | -13.64 | -102.6 | -190.7 | 157.26 | -435.46 | -281.66 |
Debt/Equity(x) | 1.13 | 0.87 | 0.16 | 0.03 | 0.02 | 0.01 | 0.04 | 0 | 0 | 0 | 0 |
Current Ratio(x) | 0.55 | 0.41 | 0.87 | 1.94 | 2.16 | 3.24 | 2.63 | 2.69 | 5.23 | 4.18 | 2.36 |
Quick Ratio(x) | 0.5 | 0.36 | 0.97 | 1.44 | 1.64 | 2.99 | 2.49 | 2.61 | 4.73 | 3.54 | 2 |
Interest Cover(x) | 1.03 | -1.5 | -156.22 | -58.32 | 9.31 | 52.83 | -0.98 | -1.99 | 1.78 | 1.07 | -19.97 |
Total Debt/Mcap(x) | 2.82 | 3.65 | 1.03 | 0.03 | 0.01 | 0.01 | 0.04 | 0.02 | 0.01 | 0.01 | 0 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 41.77 | 42.23 | 42.23 | 42.23 | 42.23 | 42.23 | 42.23 | 37.73 | 37.73 | 37.73 |
FII | 0.04 | 0.18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.3 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.16 | 6.21 |
Public | 58.2 | 57.59 | 57.77 | 57.77 | 57.77 | 57.77 | 57.77 | 62.27 | 53.11 | 53.76 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 2.69 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.74 | 2.96 | 2.96 | 2.96 |
FII | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.18 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.72 | 0.49 |
Public | 3.75 | 3.74 | 3.75 | 3.75 | 3.75 | 3.75 | 3.75 | 4.88 | 4.16 | 4.21 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6.44 | 6.49 | 6.49 | 6.49 | 6.49 | 6.49 | 6.49 | 7.84 | 7.84 | 7.84 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About